- Home
- CPRI vs VCEL Comparison
CPRI vs VCEL Comparison
Compare CPRI & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRI
- VCEL
- Stock Information
- Founded
- CPRI 1981
- VCEL 1989
- Country
- CPRI United Kingdom
- VCEL United States
- Employees
- CPRI N/A
- VCEL N/A
- Industry
- CPRI Apparel
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CPRI Consumer Discretionary
- VCEL Health Care
- Exchange
- CPRI Nasdaq
- VCEL Nasdaq
- Market Cap
- CPRI 2.6B
- VCEL 2.8B
- IPO Year
- CPRI 2011
- VCEL 1997
- Fundamental
- Price
- CPRI $23.81
- VCEL $59.07
- Analyst Decision
- CPRI Buy
- VCEL Strong Buy
- Analyst Count
- CPRI 11
- VCEL 7
- Target Price
- CPRI $27.55
- VCEL $62.29
- AVG Volume (30 Days)
- CPRI 2.8M
- VCEL 424.2K
- Earning Date
- CPRI 02-05-2025
- VCEL 02-27-2025
- Dividend Yield
- CPRI N/A
- VCEL N/A
- EPS Growth
- CPRI N/A
- VCEL N/A
- EPS
- CPRI N/A
- VCEL 0.07
- Revenue
- CPRI $4,796,000,000.00
- VCEL $226,844,000.00
- Revenue This Year
- CPRI N/A
- VCEL $23.82
- Revenue Next Year
- CPRI $0.76
- VCEL $22.51
- P/E Ratio
- CPRI N/A
- VCEL $821.76
- Revenue Growth
- CPRI N/A
- VCEL 22.48
- 52 Week Low
- CPRI $18.70
- VCEL $38.69
- 52 Week High
- CPRI $50.62
- VCEL $61.49
- Technical
- Relative Strength Index (RSI)
- CPRI 60.19
- VCEL 57.96
- Support Level
- CPRI $22.76
- VCEL $53.00
- Resistance Level
- CPRI $24.08
- VCEL $60.93
- Average True Range (ATR)
- CPRI 0.83
- VCEL 2.60
- MACD
- CPRI 0.39
- VCEL -0.06
- Stochastic Oscillator
- CPRI 83.60
- VCEL 76.54
About CPRI Capri Holdings Limited
Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Michael Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. John Idol has served as CEO since 2003.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in various therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.